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Summary
Focal adhesion kinase (FAK) is an important mediator
of integrin signaling in the regulation of cell prolifera-
tion, survival, migration, and invasion. To understand
how FAK contributes to cell invasion, we explored the
regulation of matrix metalloproteinases (MMPs) by
FAK. We found that v-Src-transformed cells activate
a FAK-dependent mechanism that attenuates endocy-
tosis of MT1-MMP. This in turn increases cell-surface
expression of MT1-MMP and cellular degradation of
extracellular matrix. Further, we identified an interac-
tion between FAK’s second Pro-rich motif and en-
dophilin A2’s SH3 domain. This interaction served as
an autophosphorylation-dependent scaffold to allow
Src phosphorylation of endophilin A2 at Tyr315.
Tyr315 phosphorylation inhibited endophilin/dynamin
interactions, and blockade of Tyr315 phosphorylation
promoted endocytosis of MT1-MMP. Together, these
results suggest a regulatory mechanism of cell inva-
sion whereby FAK promotes cell-surface presentation
of MT1-MMP by inhibiting endophilin A2-dependent
endocytosis.
Introduction
Metastatic tumors can spread to different organs,
which is usually associated with a poor prognosis for
cancer patients (Chambers et al., 2002; Hanahan and
Weinberg, 2000). In order to metastasize, neoplastic
cells must invade and migrate into surrounding tissues.
Tumor cell invasion is a complex process that involves
the secretion and activation of proteases that degrade
the extracellular matrix (ECM), alterations in integrin
surface expression, and changes in gene expression
during cell transformation (Egeblad and Werb, 2002;
Hood and Cheresh, 2002; McCawley and Matrisian,
2000). Consistent with the complexity of the cell inva-
sion process, changes in the expression or activities of
a variety of cellular proteins have been implicated in
the regulation of this process.
Focal adhesion kinase (FAK) is a cytoplasmic tyrosine
kinase that plays a key role in integrin-mediated signal-
ing pathways (Parsons, 2003; Schlaepfer and Mitra,
2004). Overexpression and increased phosphorylation
of FAK have been found in a variety of human cancer
samples (Owens et al., 1995), and these changes are
correlated with the acquisition of an invasive pheno-
type and enhanced metastasis (Cance et al., 2000;
Kornberg, 1998). Interestingly, recent studies showed*Correspondence: jg19@cornell.eduthat overexpression of FRNK in v-Src-transformed NIH
3T3 fibroblasts inhibited cell invasion and blocked ex-
perimental metastases in nude mice (Hauck et al.,
2002), suggesting a potential role of FAK in the regu-
lation of cell invasion. Furthermore, differential FAK
downstream pathways were found to regulate cell inva-
sion and migration (Hsia et al., 2003).
Transformation of fibroblasts by viral Src (v-Src) pro-
vides a well-characterized model system for study
of regulatory mechanisms involved in tumor cell inva-
sion. V-Src can promote the formation of podosomes
(Tarone et al., 1985), which are the most prominent part
of actin cytoskeleton of monocyte-derived cells, some
transformed fibroblasts, and certain carcinoma cells.
Podosomes contain multiple structural and signaling
molecules including F-actin, Src, PI3-kinase, integrins,
cortactin, vinculin, N-WASP, and FAK (Linder and
Aepfelbacher, 2003). Secreted and membrane bound
matrix metalloproteinases (MMPs) (e.g., MT1-MMP) are
also localized to podosomes, which results in local ex-
tracellular proteolytic activity at these sites (Delaisse et
al., 2000; Sato et al., 1997). MMPs are multidomain
zinc-dependent proteinases that play pivotal roles in
tumor cell invasion. MT1-MMP is anchored to the
plasma membrane via specialized domains and thus is
suited for pericellular proteolysis (Seiki, 2003). Recent
study identified MT1-MMP as the major cell-associated
proteinase necessary to confer normal or neoplastic
cells with invasive activity (Sabeh et al., 2004). Mem-
brane anchoring also confers MT1-MMP a unique regu-
latory mechanism to allow cells to control MT1-MMP-
dependent proteolytic activity through regulation of its
endocytosis and surface presentation (Jiang et al.,
2001; Remacle et al., 2003; Uekita et al., 2001).
Endophilins are a family of evolutionarily conserved
proteins that can bind to the cytoplasmic face of mem-
branes (Schmidt et al., 1999; Reutens and Begley,
2002). Endophilin family consists of two subgroups, en-
dophilin A and endophilin B. The A subfamily consists
of three members. Endophilin A1 is restricted in neu-
rons; endophilin A2 is ubiquitously expressed; and en-
dophilin A3 is enriched in neurons and testis. Several
lines of evidence have indicated the critical role of en-
dophilins, particularly endophilin A1 (which is the most
extensively studied), in both early and late stages of
endocytosis. Both the N-terminal BAR domain and C-ter-
minal SH3 domain of endophilins are critical for its
function in endocytosis. The N-terminal portion of en-
dophilin A1 contains a BAR domain that encodes lyso-
phosphatidic acid acyl transferase (LPAAT) activity by
which arachidonate was transferred to the inverted
cone-shaped lysophosphatidic acid to generate cone-
shaped phosphatidic acid. Thus, endophilin was hy-
pothesized to induce positive-to-negative lipid mem-
brane curvature, which facilitates vesicle formation
(Schmidt et al., 1999). In addition to the LPAAT activity,
the N-terminal region of endophilin A1 has also been
shown to induce tubulation of liposome (Farsad et al.,
2001). The SH3 domain of endophilin can associate
with synaptojanin-1 and dynamin, and these protein-
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186Figure 1. FAK Regulation of Surface Expression and Endocytosis of MT1-MMP, MMP2 Activation, and ECM Degradation
(A) Surface proteins as labeled by biotinylation followed by streptavidin precipitation (top) or total lysates (WCL, middle) from FAK−/−Src or
FAK+/+Src cells were analyzed by immunoblotting with anti-MT1-MMP. Conditioned media from these cells were subjected to in-gel gelatinase
assay as described in the Experimental Procedures, and the activated MMP2 band is marked by an arrow on the right (bottom).
(B) FAK−/−Src or FAK+/+Src cells (left) and FAK−/−Src cells infected with control Ad-GFP or Ad-FAK (right) were biotinylated on ice, warmed to
37°C for 15 min to allow internalization, and then treated with glutathione to remove cell-surface biotin (15 min). Cells that were stripped by
glutathione directly after biotinylation without incubation in 37°C served as negative control (0 min), while cells (1/5 of total) that were lysed
directly after labeling without stripping by glutathione were used as positive control (1/5 +). Biotinylated proteins were precipitated by strepta-
vidin and analyzed by immunoblotting using anti-MT1-MMP (top). Aliquots of the lysates (WCL) were also analyzed directly by Western
blotting with anti-vinculin to verify that similar amount of lysates were used (bottom).
(C) FAK−/−Src cells infected with control Ad-GFP or Ad-FAK or noninfected cells were analyzed for their ability to activate MMP2 as described
in (A).
(D) FAK+/+Src (a, c) and FAK−/−Src (b, d) cells were trypsinized and plated on glass coverslips coated with FITC-labeled FN as described in
Experimental Procedures. After 6 hr, cells were fixed in methanol and stained with Hoechst to view cell nuclei (c, d) and clearance of FITC-
FN (dark spots on the green background; a, b).
(E) FAK−/−Src cells infected with control Ad-GFP or Ad-FAK as well as uninfected cells were analyzed for FITC-FN degradation as described
in (D). The percentages of cells that have degraded FN were determined. Mean cell counts from multiple fields and three experiments are
shown. Error bars represent standard deviations.
(F) FAK+/+Src cells were cotransfected with plasmid encoding GST and plasmids encoding a control RNAi (1) or MT1-MMP RNAi (2). ECM
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187Figure 1B shows that less MT1-MMP was endocytosed control Ad-GFP, which is consistent with the reduced
degradation by the transfected cells (as marked by anti-GST staining) were analyzed at 3 days after transfection as described in (E). Inset
shows Western blotting of lysates from control (left) or MT1-MMP (right) RNAi-treated cells with anti-MT1-MMP (top) or anti-vinculin (bottom).
(G and H) FAK−/−Src cells were infected with various adenoviruses as indicated.
(G) 2 days after infection, surface expression of MT1-MMP was determined as described in (A) (top). Aliquots of the lysates (WCL) were
analyzed directly by Western blotting with anti-vinculin (middle) or anti-HA (bottom).
(H) Cells were analyzed for ECM degradation as described in (E).
(I) FAK−/−Src cells were infected with various adenoviruses as indicated. They were then analyzed for ECM degradation as described in (E).
Inset shows Western blotting of samples from Ad-FAK (left) or Ad-KD (right) infected cells with anti-PY397 (top) or anti-FAK (bottom).protein interactions are required for endocytosis (Reu-
tens and Begley, 2002).
In this study, we investigated potential mechanisms
of FAK regulation of cell invasion. We found that FAK
can regulate endocytosis of MT1-MMP to increase its
surface expression and cellular degradation of ECM.
Furthermore, we identified an interaction between FAK
and endophilin A2 and showed that this interaction al-
lows tyrosine phosphorylation of endophilin A2 at Y315
by a FAK/Src complex. This phosphorylation event then
inhibits endophilin/dynamin interactions, attenuating
endocytosis of MT1-MMP. In this way, FAK upregulates
surface expression of MT1-MMP and consequent abil-
ity of cells to degrade ECM. These results reveal a
mechanism of regulation of cell invasion by FAK.
Results
Regulation of Endocytosis and Surface Expression
of MT1-MMP by FAK
MT1-MMP is a membrane bound MMP, whose expres-
sion on the cell surface plays an important role in inva-
sion (Sabeh et al., 2004; Seiki, 2003). To study potential
mechanisms of FAK function in cell invasion, we tested
its role in the regulation of MT1-MMP in transformed
cells using FAK−/− and FAK+/+ MEFs with stable expres-
sion of v-Src (designated as FAK−/−Src and FAK+/+Src
cells, respectively). Western blotting analysis of cell ly-
sates shows that expression levels of MT1-MMP were
similar in FAK+/+Src and FAK−/−Src cells (Figure 1A,
middle). However, as a membrane bound proteinase,
the function of MT1-MMP requires its cell-surface pre-
sentation. Thus, we examined surface expression of
MT1-MMP in these cells. Figure 1A shows an increased
presence of MT1-MMP on the surface of FAK+/+Src
cells compared to FAK−/−Src cells (top). Consistent with
this, increased activation of MMP-2 (a MT1-MMP sub-
strate activated by cell-surface MT1-MMP) (Seiki, 2003)
was found in FAK+/+Src cells compared to FAK−/−Src
cells (bottom). These results suggest that FAK influ-
ences subcellular localization of MT1-MMP.
Differential endocytosis of MT1-MMP has been re-
cently proposed as a mechanism of altered surface ex-
pression and regulation of its function in invasion (Jiang
et al., 2001; Remacle et al., 2003; Uekita et al., 2001).
Consistent with findings in other cells (Remacle et al.,
2003), we found that MT1-MMP was internalized
through the early and late endosomes as detected by
colocalization with respective markers (see Figure S1
in the Supplemental Data available with this article on-
line). Thus, we examined whether FAK can regulate en-
docytosis of MT1-MMP to affect its surface expression.in FAK+/+Src cells compared with that in FAK−/−Src cells
(left panels), suggesting a possible role for FAK in the
regulation of endocytosis of MT1-MMP. To confirm this,
we used recombinant adenovirus encoding FAK (Ad-
FAK) to express FAK in FAK−/−Src cells. Consistent with
results comparing FAK−/−Src and FAK+/+Src cells, infec-
tion of FAK−/−Src cells with Ad-FAK, but not control Ad-
GFP, reduced the rate of MT1-MMP endocytosis (Figure
1B, right panels) and increased cell-surface expression
of MT1-MMP (see Figure 1G) and activation of MMP2
(Figure 1C). These results suggest that reduced endo-
cytosis may be responsible for the higher surface ex-
pression of MT1-MMP in FAK+/+Src cells compared to
FAK−/−Src cells.
A major role of MMPs is degradation of ECM to facili-
tate cell invasion (McCawley and Matrisian, 2000). Thus,
we next examined the effect of altered surface expres-
sion of MT1-MMP by FAK in the degradation of ECM
by in situ zymography assays. Cells were incubated on
dishes that had been coated with FITC-labeled fibro-
nectin (FN) to measure their ability to degrade FN as
determined by the clearance of FITC-FN and appear-
ance of dark patches on the green background. After 6
hr of incubation, the majority of FAK+/+Src cells showed
degradation of FITC-FN whereas few FAK−/−Src cells
were associated with FN degradation patches (Figure
1D). FAK−/− and FAK+/+ parental cells did not degrade
FITC-FN under the same condition (data not shown).
Infection of FAK−/−Src cells with Ad-FAK significantly
rescued their ability to degrade ECM compared to cells
infected with control Ad-GFP or noninfected cells (Fig-
ure 1E). These results suggested that increased surface
expression of MT1-MMP by FAK may be responsible
for v-Src-induced ECM degradation, which is a critical
step in cell invasion. Consistent with this, we also found
that MT1-MMP knockdown by RNAi reduced degrada-
tion of FITC-FN in FAK+/+Src cells (Figure 1F), providing
further support that ECM degradation induced by FAK/
Src complex is through its effect on MT1-MMP.
The Autophosphorylated Y397 and Second Pro-Rich
Motif of FAK C-Terminal Domain Are Required
for Its Regulation of Surface Expression
of MT1-MMP and ECM Degradation
To further analyze the role of FAK in the regulation of
surface expression of MT1-MMP and ECM degrada-
tion, we examined the ability of FAK or its mutants to
promote surface expression of MT1-MMP and ECM
degradation when introduced into FAK−/−Src cells. Fig-
ure 1G shows that infection of these cells with Ad-FAK
increased MT1-MMP expression on the cell surface
compared with noninfected cells or cells infected with
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188Figure 2. Association of FAK with Endophilin A2
(A) Alignment of the second C-terminal Pro-rich motif in different species of FAK, corresponding sequence in human Pyk2, and the first C-terminal
Pro-rich motif of chicken FAK.
(B) Lysates from FAK−/−Src, FAK+/+Src cells, and mice brain were analyzed by Western blotting with different antibodies as indicated.
(C) Immobilized GST fusion proteins or GST were incubated with lysates from 293T cells that had been transfected with pKH3-FAK encoding
HA-tagged FAK. After washing, the bound proteins were analyzed by Western blotting with anti-HA (top), and the same membranes were
stained with Ponceau S to verify similar levels of GST fusion proteins (bottom).
(D and E) 293T cells were cotransfected with pKH3-FAK, P878,881A mutant, or vector as a control, and plasmids encoding Myc-tagged
endophilin A2, its W343K mutant, or vector alone as a control, as indicated. Cell lysates were immunoprecipitated with anti-Myc (D) or anti-
HA (E) followed by Western blotting with antibodies as indicated. Aliquots of the lysates (WCL) were also analyzed directly by Western blotting
as indicated (middle).
(F) Lysates from FAK+/+Src cells were immunoprecipitated by anti-endophilin A2 or the control goat IgG, as indicated. The precipitates or
aliquots of the lysates (WCL) were analyzed by Western blotting with different antibodies as indicated.
(G) Purified recombinant FAK was incubated with immobilized GST or GST fusion protein containing endophilin A2 (GST-EndoII), as indicated.
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189duced level with the W343K mutant and was not pre- and plasmids encoding FAK, Src (Y527 to F mutation,
After washing, the bound proteins as well as an aliquot of the input were analyzed by Western blotting with anti-FAK (top), and GST or GST-
EndoII were also stained with Commassie blue to show similar amounts in the samples and purity (bottom).
(H) FAK+/+Src cells were replated on FN-coated coverslips and subjected to double immunofluorescent staining with phalloidin (a) and anti-
FAK (b), with phalloidin (c) and anti-endophilin A2 (d), with a monoclonal anti-FAK (e) and a polyclonal anti-endophilin A2 (f), or with phalloidin
(g) and anti-MT1-MMP (h). Arrows mark the podosomes.endocytosis (see Figure 1B). Interestingly, infection of
these cells with either Ad-Y397F or Ad-P878/881A en-
coding FAK mutation of Y397 to F or P878 and P881 to
As, respectively, did not stimulate surface expression
of MT1-MMP. Consistent with the surface expression of
MT1-MMP, we found that infection of FAK−/−Src cells
with Ad-FAK, but not Ad-Y397F, Ad-P878/881A, or con-
trol Ad-GFP, stimulated ECM degradation (Figure 1H).
We also found that the FAK kinase-defective mutant,
which is not phosphorylated at Y397, did not increase
ECM degradation of FAK−/−Src cells (Figure 1I). To-
gether, these results suggest that both FAK autophos-
phorylation at Y397 and the second Pro-rich motif of
FAK C-terminal domain are required for its regulation of
surface expression of MT1-MMP and ECM degradation.
Association of FAK with Endophilin A2
As Y397 to F mutation abolishes essentially all FAK down-
stream signaling functions (Parsons, 2003; Schlaepfer
and Mitra, 2004), we focused on examining the potential
downstream target of FAK that may interact with its
second Pro-rich motif in the regulation of endocytosis
and surface expression of MT1-MMP. Interestingly, we
found that the residues 875–881 of FAK surrounding the
second Pro-rich motif in the C-terminal domain is con-
served among human, mouse, and chicken and also
closely matches the Pro-rich motif for binding the SH3
domains of endophilins that play important roles in en-
docytosis (Figure 2A; Cestra et al., 1999). Three en-
dophilins have been described: endophilin A2 is ubiqui-
tously expressed in many cell types while endophilin A1
is restricted in neurons and endophilin A3 is enriched in
neurons and testes (Ringstad et al., 1997). Analysis of
lysates from FAK+/+Src and FAK−/−Src cells showed that
endophilin A2, but not endophilin A1 or endophilin A3,
is expressed in these cells (Figure 2B). To test a poten-
tial interaction of FAK with endophilin A2, we prepared
the GST fusion proteins containing the full-length en-
dophilin A2, its SH3 domain, and a deletion construct
lacking the SH3 domain (SH3), and we performed in
vitro GST pull-down assays. Figure 2C shows that FAK
bound GST-endophilin A2 and the SH3 domain (lanes 2
and 3), but not SH3 or GST alone (lanes 1 and 4). The
related kinase Pyk2 with less homology with the con-
sensus sequence (see Figure 2A) did not bind GST-
endophilin A2 in similar assays (data not shown), sup-
porting the specificity of the interaction between FAK
and endophilin A2.
To detect this interaction in intact cells, 293T cells
were cotransfected with pKH3-FAK encoding HA-
tagged FAK and plasmids encoding Myc-tagged en-
dophilin A2, the W343K mutant that disrupts the key W
residue in its SH3 domain, or vector alone as a control.
Coimmunoprecipitation of the lysates showed that FAK
associated with endophilin A2, but at a significantly re-sent in the control sample (Figure 2D). Similarly, analy-
sis via cotransfections showed that mutation of the
P878 and P881 of FAK to Ala (P878/881A mutant) signi-
ficantly reduced its interaction with endophilin A2
(Figure 2E). Furthermore, consistent with the in vitro
binding and transfection studies, association of endog-
enous endophilin A2 and FAK was also detected by
coimmunoprecipitation (Figure 2F).
Lastly, we prepared a GST fusion protein containing
endophilin A2 (GST-Endo II) in bacteria to determine
whether the interaction between endophilin A2 and FAK
is direct or not. As shown in Figure 2G, purified His-
tagged recombinant FAK protein from insect Sf21 cells
bound to immobilized purified GST-Endo II, but not GST
alone control, suggesting that FAK was capable of in-
teracting with endophilin A2 directly. Together, these re-
sults demonstrated a FAK interaction with endophilin
A2 mediated by the FAK Pro-rich region of 875–881 and
the SH3 domain of endophilin A2, which could be re-
sponsible for FAK regulation of endocytosis and sur-
face expression of MT1-MMP.
We also examined the subcellular localization of FAK
and endophilin A2 by indirect immunofluorescence in
FAK+/+Src cells. In agreement with previous findings
(Ochoa et al., 2000), Figure 2H shows both endogenous
FAK and endophilin A2 colocalized with F-actin at po-
dosomes in these cells (panels a–d). Colocalization of
FAK and endophilin A2 at podosomes was also verified
by coimmunofluorescent staining with anti-FAK and
anti-endophilin A2 antibodies (panels e and f). Lastly,
MT1-MMP was also localized in the podosomes in
these cells (panels g and h), which is consistent with
previous reports showing such localization of MT1-
MMP in other cells (Delaisse et al., 2000; Sato et al.,
1997). Despite localization of FAK, endophilin A2, and
MT1-MMP in the podosomes, we found that expression
of FAK did not affect podosome formation in these
cells, suggesting that regulation of surface expression
of MT1-MMP was not due to FAK effects on the forma-
tion of podosomes (Figure S2).
Phosphorylation of Endophilin A2
by FAK/Src Complex
To evaluate whether FAK interactions with endophilin
A2 is involved in the regulation of MT1-MMP endocyto-
sis, we first tested the effect of endophilin A2 knock-
down by RNAi on the surface level of MT1-MMP. Figure
3A shows that reduction of endophilin A2 by RNAi re-
sulted in an increased expression level of MT1-MMP
on the cell surface, suggesting a role of endophilin A2
in the regulation of MT1-MMP by FAK. To further ex-
plore the potential mechanisms involved, we examined
possible tyrosine phosphorylation of endophilin A2 by
FAK or FAK/Src complex by cotransfection of 293T
cells with vector encoding Myc-tagged endophilin A2
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190Figure 3. Tyrosine Phosphorylation of En-
dophilin A2 by FAK/Src Complex
(A) FAK−/−Src cells were infected with recom-
binant adenoviruses encoding endophilin A2
RNAi or a control RNAi. 3 days after infec-
tion, surface expression of MT1-MMP was
determined as described in Figure 1A (top).
Aliquots of the lysates (WCL) were also ana-
lyzed directly by Western blotting with anti-
endophilin A2 (middle) or anti-vinculin (bottom).
(B) 293T cells were cotransfected with
pHAN-endophilin A2 and plasmids encoding
FAK, Src, both FAK and Src, or empty vector
control (V), as indicated. Lysates were immu-
noprecipitated with anti-Myc followed by
Western blotting with anti-PY (top) to detect
phosphorylation of endophilin A2 or anti-
Myc to verify similar level of endophilin A2 in
the samples (middle). The lysates (WCL)
were also analyzed directly by Western blot-
ting with anti-Src (bottom).
(C) Lysates from FAK−/−Src, FAK+/+Src, FAK−/−
and FAK+/+, MDA-MB-231, and NIH3T3 cells
were immunoprecipitated with anti-endo-
philin A2 followed by Western blotting with
anti-PY (upper). Aliquots of the lysates
(WCL) were also analyzed directly by West-
ern blotting with anti-endophilin A2 (lower).
(D) FAK+/+Src cells were treated with Src
family kinase inhibitor PP2 or its control PP3
as described in Experimental Procedures.
Surface expression of MT1-MMP was then
determined as described in Figure 1A (top).
Aliquots of the lysates (WCL) were also ana-
lyzed directly by Western blotting with anti-
MT1-MMP (bottom).
(E) 293T cells were cotransfected with vari-
ous expression vectors as indicated. Lysates
were immunoprecipitated with anti-Myc and
analyzed by Western blotting with anti-PY to
detect phosphorylation of endophilin A2, or
with anti-Src to detect association between
Src and endophilin A2. The lysates (WCL)
were also analyzed directly by Western blot-
ting with various antibodies as indicated to
detect the expression levels of endophilin
A2, FAK, and Src, respectively.
(F) Recombinant endophilin A2 was incubated in a kinase buffer with HA-tagged FAK or Src immunoprecipitated from 293T cells transfected
with corresponding expression vectors, as indicated. In vitro kinase assays were performed as described in the Experimental Procedures.which is functional equivalent of v-Src) (Cooper et al.,
c1986), or both FAK and Src. Figure 3B shows a very
weak phosphorylation of endophilin A2 by either FAK f
lor Src alone, but a strong phosphorylation by the com-
bination of FAK and Src. Consistent with these results, a
mwe found a strong phosphorylation of endogenous en-
dophilin A2 in FAK+/+Src cells, a very weak phosphory- m
plation in FAK−/−Src cells, and no phosphorylation in
FAK+/+ and FAK−/− cells (Figure 3C). We also found an e
2elevated tyrosine phosphorylation of endophilin A2 in
the metastatic breast cancer cell line MDA-MB-231 c
ocells, which has high Src kinase activity, compared to
NIH3T3 cells. Furthermore, treatment of FAK+/+Src cells p
uwith the Src family kinase inhibitor, PP2, reduced sur-
face expression of MT1-MMP when compared to cells p
ttreated with the control compound PP3 (Figure 3D). To-
gether, these results suggested that endophilin A2 may I
Mbe a substrate of FAK/Src complex and its phosphory-
lation by Src may affect its regulatory function for MT1- g
aMMP endocytosis.Previous studies on Cas phosphorylation by FAK/Src
omplex suggested that FAK may function as a scaf-
olding protein to recruit Src (via its autophosphory-
ated Y397 binding to Src SH2 domain) to phosphoryl-
te Cas (associated with FAK through its Pro-rich
otifs) (Ruest et al., 2001). To test whether such a
odel may also be the case for endophilin A2 phos-
horylation, we examined the potential association of
ndophilin A2 with Src in a FAK-dependent manner.
93T cells were transfected with expression vectors en-
oding Src, Myc-tagged endophilin A2, and pKH3-FAK
r pKH3 vector alone. The lysates were then immuno-
recipitated by anti-Myc and blotted with anti-Src. Fig-
re 3E shows that Src was not present in the immuno-
recipitates in the absence of FAK (lane 2), indicating
hat Src and endophilin A2 are not directly associated.
n the presence of FAK, however, Src is detected in the
yc-endophilin A2 immunoprecipitates (lane 3), sug-
esting that Src could associate with endophilin A2 in
n indirect manner with FAK as a scaffold. Use of the
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ments showed a significantly decreased coimmuno-
precipitation of Src and endophilin A2 (lanes 4 and 5),
providing further support for this model. Consistent
with this model, the level of endophilin A2 phosphoryla-
tion is correlated with its association with Src through
FAK. To further confirm the model, we examined
whether endophilin A2 can be phosphorylated by Src
or FAK in vitro. Purified GST-endophilin A2 fusion pro-
tein was incubated in a kinase buffer with Src or FAK
immunoprecipitated from 293T cells transfected with
vectors encoding Src or FAK and immobilized on the
beads. The samples were then resolved on SDS-PAGE
and blotted with 4G10 to detect endophilin A2 phos-
phorylation. Figure 3F shows that Src, but not FAK,
phosphorylated endophilin A2 in vitro. Together, these
results suggest that endophilin A2 is a substrate for the
FAK/Src complex and that FAK promotes endophilin A2
phosphorylation through its scaffolding role to bind Src
at Y397 and endophilin A2 at P878 and P881.
Identification of Y315 of Endophilin A2 as Major
Phosphorylation Site by FAK/Src Complex
To identify the major phosphorylation site on endophilin
A2 by FAK/Src complex, we examined phosphorylation
of several overlapping segments of endophilin A2 (Fig-
ure 4A) by Src in in vitro kinase assays as discussed
above. Figure 4B shows that while GST fusion proteins
containing the SH3 domain or the BAR segment were
phosphorylated, the SH3 or the BAR segment were
not. Because endophilin A2 contains a total of eight Tyr
residues with five in the BAR domain and three in the
SH3 domain (none between these two domains), the
above results suggested that the SH3 domain harbors
the potential phosphorylation sites. We then mutated
the three Tyr in the SH3 domain either individually or in
various combinations in the BAR context. They were
then subjected to the same in vitro kinase assays by
Src. Figure 4C shows that mutation of Y315 to F either
individually or in combination with the other two Y resi-
dues abolished phosphorylation by Src, suggesting
that Y315 is the major phosphorylation site by Src. To
verify this in the full-length context in vivo, 293T cells
were cotransfected with expression vectors encoding
FAK, Src, and Myc-tagged endophilin A2 or its Y315F
mutant. Cell lysates were immunoprecipitated by anti-
Myc and then blotted by anti-PY. Figure 4D shows that
while endophilin A2 was phosphorylated by the FAK/
Src complex, the Y315F mutant was not. Together,
these results identified Y315 of endophilin A2 as a ma-
jor phosphorylation site by FAK/Src complex.
Phosphorylation of Endophilin A2 by FAK/Src
Complex Reduces Its Interaction with Dynamin
Y315 lies in the SH3 domain of endophilin A2 responsi-
ble for its interaction with dynamin and synaptojanin
(Ringstad et al., 1997). To examine the potential effect
of endophilin A2 phosphorylation at Y315 on the in-
teraction between endophilin A2 and dynamin, 293T
cells were transfected with expression vectors encod-
ing Myc-tagged endophilin A2 or its Y315F mutant with
or without plasmids encoding FAK and Src, or vector
as control. Figure 4E shows that coexpression of en-dophilin A2 with FAK and Src led to its reduced associ-
ation with dynamin. In contrast, Y315F mutant (which
can not be phosphorylated by FAK/Src complex) asso-
ciated with dynamin was not reduced by coexpression
of FAK and Src. Analysis of GFP fusion proteins con-
taining endophilin A2 (GFP-endophilin A2) or Y315F
mutant (GFP-Y315F) showed that both are colocalized
with F-actin at podosomes in FAK+/+Src cells (Figure
4F), suggesting that reduced association of endophilin
A2 with dynamin upon phosphorylation at Y315 is not
due to its altered subcellular localization. Furthermore,
we found that phosphorylation of endophilin A2, but not
its Y315F mutant, by Src in vitro also reduced its in-
teraction with dynamin, but had little effect on its bind-
ing to FAK (Figure 4G; see Figure S3 for efficient phos-
phorylation of endophilin A2 by Src). To further test the
role of phosphorylation of endophilin A2 at Y315 on its
association with dynamin, we created another point
mutant of endophilin A2 converting Y315 to E (Y315E),
mimicking the negative charges created by phosphory-
lation. Association of the endophilin A2 mutants with
dynamin were then analyzed by coimmunoprecipitation
assays. Figure 4H shows that Y315E mutant exhibited
significantly decreased association with dynamin com-
pared to wild-type endophilin A2 and Y315F mutant.
However, this mutant showed only slight reduction in
association with FAK (Figure 4I), suggesting specific
regulation of endophilin A2 interaction with dynamin by
phosphorylation of Y315. Together, these results sug-
gested that phosphorylation of endophilin A2 at Y315
by FAK/Src complex may reduce its association with
dynamin and lead to reduced endocytosis of MT1-
MMP.
Interaction of Endophilin A2 with FAK and Its
Consequent Phosphorylation Regulate Surface
Expression of MT1-MMP and ECM Degradation
Interactions between endophilins and dynamin or syn-
aptajanin are critical for clathrin-dependent endocyto-
sis pathway. This raises the interesting possibility that
phosphorylation of endophilin A2 by FAK/Src complex
is responsible for the decreased endocytosis of MT1-
MMP and its increased surface expression in FAK+/+Src
cells. Such a possibility is also consistent with the ob-
servation that reexpression of FAK, but not Y397F or
P878/881A mutant lacking the scaffolding role to allow
endophilin A2 phosphorylation by FAK/Src complex
(see Figure 3E), increased surface expression of MT1-
MMP in FAK−/−Src cells (see Figure 1G). To further test
this possibility, we prepared recombinant adenoviruses
encoding Y315F mutant of endophilin A2 that can not
be phosphorylated by FAK/Src complex (Ad-Y315F) as
well as that encoding wild-type endophilin A2 as a con-
trol (Ad-EndoII). FAK+/+Src cells were infected with
these adenoviruses, and the effects on the surface ex-
pression and endocytosis of MT1-MMP as well as ECM
degradation were examined. We found that expression
of the Y315F mutant, but not wild-type endophilin A2 or
control Ad-GFP, decreased surface expression of MT1-
MMP (Figure 5A), which correlated with its stimulation
of MT1-MMP endocytosis (Figure 5B). Consistent with
the increased endocytosis and decreased surface ex-
pression of MT1-MMP, the ability to degrade ECM was
Developmental Cell
192Figure 4. Phosphorylation of Endophilin A2 at Y315 by FAK/Src Complex and Effect on Endophilin A2 Interaction with Dynamin
(A) Schematic diagram of endophilin A2 and its segments used in the in vitro kinase assay in (B).
(B) GST fusion proteins containing endophilin A2 segments were prepared and subject to in vitro kinase assay by Src as described in
Experimental Procedures.
(C) GST fusion proteins containing endophilin A2 BAR segment or its various mutants were subject to in vitro kinase assay by Src as
described in (B).
(D) 293T cells were cotransfected with pHAN-endophilin A2 or pHAN-endophilin A2-Y315F and FAK and Src as indicated. Lysates were
immunoprecipitated with anti-Myc and analyzed by Western blotting with anti-PY (top) or anti-Myc (bottom).
(E) 293T cells were transfected with expression vectors encoding Myc-tagged endophilin A2 or Y315F mutant, FAK and Src, or vector alone
control (V), as indicated. Lysates were prepared and immunoprecipitated with anti-Myc. The precipitates or aliquots of the lysates (WCL) were
analyzed by Western blotting with various antibodies as indicated.
(F) FAK+/+Src cells were transfected with vectors encoding GFP-tagged endophilin A2 (a, b) or Y315F mutant (c, d). Transfected cells were
stained with phalloidin (b, d). GFP fusion proteins were observed directly by fluorescence microscopy (a, c). Arrows mark the podosomes.
(G) Purified GST fusion proteins containing endophilin A2 (GST-EndoII) or Y315F mutant (GST-Y315F) were incubated with or without Src
immobilized on agarose beads, as indicated. After removing the beads with Src, the samples were diluted and incubated with lysates from
293T cells, and glutathione beads were added to pull down GST fusion proteins and associated proteins. They were then analyzed by Western
blotting with anti-dynamin (top) or anti-FAK (bottom).
(H and I) 293T cells were transfected with expression vectors encoding HA-tagged endophilin A2 or its point mutants as indicated, or vector
alone control (V), as well as a vector encoding Myc-FAK (I), as indicated. Lysates were prepared and immunoprecipitated with anti-HA and
analyzed by Western blotting with anti-dynamin ([H], top), anti-Myc ([I], top), or anti-HA (bottom). Aliquots of the lysates (WCL) were also
analyzed directly by Western blotting with anti-dynamin ([H], middle) or anti-Myc (I, middle).also reduced in the cells infected with Ad-Y315F, but b
enot Ad-EndoII or control Ad-GFP (Figure 5C). Together,
these results strongly suggest that endophilin A2 in- f
fteraction with FAK and its subsequent phosphorylationy the FAK/Src complex is responsible for the reduced
ndocytosis of MT1-MMP leading to its increased sur-
ace expression and ECM degradation in Src-trans-
ormed cells.
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Degradation by a Dominant-Negative Mutant of Endophilin A2
FAK+/+Src cells were infected with various adenoviruses as indi-
cated.
(A) 2 days after infection, surface expression of MT1-MMP was de-
termined as described in Figure 1A (top). Aliquots of the lysates
(WCL) were also analyzed directly by Western blotting with anti-
vinculin (middle) or anti-HA (bottom).
(B) Endocytosis of MT1-MMP in the infected cells was analyzed as
described in Figure 1B.
(C) Cells were trypsinized and plated on glass coverslips coated
with FITC-labeled FN, and ECM degradation was determined as
described in Figure 1E.Discussion
Expression and activation of MMPs and consequent
cellular degradation of ECM are critical steps of tumor
invasion and metastasis (McCawley and Matrisian,
2000). MT1-MMP is a membrane bound MMP whose
expression on the cell surface plays important roles in
the activation of other MMPs such as MMP2 in cell in-
vasion. Recent studies also suggested a direct role for
MT1-MMP in tumor cell invasion (Sabeh et al., 2004;
Seiki, 2003). Using a v-Src-transformed fibroblasts
model, we show here that FAK can promote cell-sur-
face expression of MT1-MMP by decreasing its endo-
cytosis, which correlates with increased cellular degra-
dation of ECM. Besides identifying FAK as a regulator
of MT1-MMP expression on the cell surface, our
studies also provide mechanistic insights into the po-
tential role of FAK in the regulation of tumor cell inva-
sion and metastasis.
Our data suggest that FAK regulates endocytosis and
surface expression of MT1-MMP by its interaction with
endophilin A2 and functioning as a scaffold to recruitSrc to phosphorylate endophilin A2. We identified an
interaction between FAK and endophilin A2 through its
second Pro-rich motif in the C-terminal domain and en-
dophilin A2 SH3 domain. Mutation of either this Pro-
rich motif or the binding site for Src, Y397, reduced en-
dophilin A2 association with and phosphorylation by
Src (through FAK as a molecular bridge) and the ability
of the mutants to promote cell-surface expression of
MT1-MMP and consequent ECM degradation when in-
troduced into FAK−/−Src cells. Furthermore, the kinase-
defective FAK could not increase ECM degradation in
FAK−/−Src cells due to its inability to autophosphorylate
Y397 in the FAK null background, suggesting that FAK
functions as a “autophosphorylation-dependent (or
switchable) scaffold” for endophilin A2 phosphorylation
by FAK/Src complex. Other tyrosine kinases (such as
Src) have also been shown to function as adaptors to
enhance phosphorylation (Brunton et al., 2005).
The second Pro-rich motif of FAK is also the binding
site for other cellular proteins including Graf, ASAP1,
and amphiphysin (Hildebrand et al., 1996; Liu et al.,
2002; Messina et al., 2003). While possible roles of Graf
and ASAP1 in endocytosis are not reported, amphi-
physin is implicated in the regulation of endocytosis by
a number of studies (Wigge and McMahon, 1998). It is
not clear, however, whether any of the above molecules
are phosphorylated by FAK/Src complex as in the case
of endophilin A2, which is correlated to the effects on
cell-surface expression of MT1-MMP and ECM degra-
dation. Therefore, although we can not completely ex-
clude the potential role of other cellular proteins in me-
diating FAK regulation of endocytosis and surface
expression of MT1-MMP, the above data together with
the analysis of endophilin A2 phosphorylation site mu-
tants (see below) strongly suggest a role for endophilin
A2 association with FAK and its phosphorylation by
FAK/Src complex in the process.
To further validate the role of FAK interaction with
endophilin A2 in the regulation of MT1-MMP endocyto-
sis and surface expression, we determined the phos-
phorylation site of endophilin A2 by FAK/Src complex
at Y315 in the SH3 domain. The crystal structure of en-
dophilin A2 or its SH3 domain is unknown at present.
However, homology modeling of this domain alone and
its complex with the peptide ligand from dynamin using
SH3 domains of Grb2 and SEM-5 as templates sug-
gested that Y315 is in close contact with a Pro residue
of the Pro-rich motif of the ligand (Figure 6A). It is likely
that this hydrophobic interaction contributes to the as-
sociation of the SH3 domain and the Pro-rich ligand.
Interestingly, the Tyr residue in Grb2 SH3 domain corre-
sponding to the Y315 of endophilin A2 is located in the
S1 subsite, which is a relatively shallow hydrophobic
pocket primarily composed of two Tyr or Phe side
chains that mediates SH3 domain association with Pro
residues in the Pro-rich ligand (Wittekind et al., 1997).
Therefore, phosphorylation of this residue (i.e., Y315 of
endophilin A2) could bring negative charges to a hy-
drophobic environment, leading to reduced association
with the ligand. This idea is supported by several previ-
ous studies showing that phosphorylation of tyrosine
residue in the SH3 domains of Src and Btk reduced
their interaction with ligands (Broome and Hunter, 1997;
































Figure 6. Models for Endophilin A2 SH3 Domain and Regulation of
Cell Invasion by FAK/Src Complex
c
(A) PDBviewer program was used to model endophilin SH3 domain
wbased on SH3 domains of Grb2 and SEM-5 as templates. Left panel
nshows the location of Y315 in the endophilin A2 SH3 domain. Right
cpanel shows Y315 of endophilin A2 SH3 domain in contact with Pro
residues of the Pro-rich ligand peptide. p
(B) A working model summarizing regulation of cell invasion by f
FAK/Src complex. Association of endophilin A2 with FAK at the l
second Pro-rich motif of the C-terminal domain allows its phos- p
phorylation by Src bound to FAK at autophosphorylated Y397. This
cphosphorylation at Y315 of endophilin A2 reduces its interaction
twith dynamin, which leads to reduced endocytosis of MT1-MMP
tand its increased cell-surface expression. Increased surface MT1-
MMP helps to activate MMP2 and increase cell invasion. c
l
t
phosphorylation of endophilin A2 by the FAK/Src com- K
plex reduced its interaction with dynamin. Furthermore, g
blockage of this phosphorylation reduced cell-surface p
expression of MT1-MMP by increasing its endocytosis, t
and consequently resulted in a reduction in ECM degra- s
dation in FAK+/+Src cells. Several studies suggested t
that MT1-MMP is regulated by endocytosis (Remacle
et al., 2003; Uekita et al., 2001). Interestingly, a recent a
report showed that inhibition of dynamin-mediated en- p
docytosis by expression of dominant-negative dynamin b
mutant K44A resulted in elevated MT1-MMP activity on s
dthe cell surface (Jiang et al., 2001). These provide fur-
mther support for our hypothesis that endophilin A2 as-
tsociation with FAK and its phosphorylation by FAK/Src
scomplex regulate surface expression of MT1-MMP and
ECM degradation through disruption of endophilin A2
Ecomplex with dynamin and inhibition of MT1-MMP en-
docytosis. A working model summarizing these results A
is shown in Figure 6B.As ECM degradation is a critical step of cell invasion,ur results showing regulation of MT1-MMP surface ex-
ression and ECM degradation by FAK is consistent
ith the previous report suggesting a role for FAK in
rc-induced cell invasion (Hsia et al., 2003). Further-
ore, FAK activation of the Cas/Rac/JNK signaling
athway is suggested to be responsible for its ability
o promote cell invasion in the previous studies. This is
n part based on the finding that mutation of both Pro-
ich motifs in the C-terminal FAK (i.e., P715,718A/
878,881A) abolished FAK’s ability to rescue invasion
efects of Src-transformed FAK−/− cells. Our findings of
role for FAK interaction with endophilin A2 through
he second Pro-rich region (i.e., P878,881) in the same
rocess raise the interesting possibility that disruption
f FAK interaction with endophilin A2 in the P715,718A/
878,881A mutant may also contribute to the defect
bserved in the previous studies (Hsia et al., 2003).
Although a potential function of FAK in endocytosis
as not been reported before, our findings on the regu-
ation of MT1-MMP endocytosis raises the intriguing
ossibility that FAK may also regulate endocytosis of
ther cell-surface proteins. However, we found that en-
ocytosis of transferrin receptor was similar between
AK+/+Src and FAK−/−Src cells (Figure S4). This sug-
ests that phosphorylation of endophilin A2 regulates
ndocytosis of some proteins such as MT1-MMP, but
ot other proteins such as transferrin receptor. It is pos-
ible that endocytosis of other endophilin A2 target
roteins like transferrin receptor is through a pool of
ndophilin A2 (and its functional complex with dy-
amin) that might not be phosphorylated by FAK/Src
omplex under these conditions. Consistent with this,
e found that only a relatively small fraction of endoge-
ous endophilin A2 was phosphorylated in FAK+/+Src
ells (Figure S5). Previous studies have also suggested
otential differential regulation of endocytosis of dif-
erent cell-surface proteins. It has been reported that at
east two functionally and biochemically distinct sub-
opulations of clathrin-coated pits are present in the
ells that could mediate agonist-regulated internaliza-
ion of the β2-AR and constitutive endocytosis of the
ransferrin receptor (Cao et al., 1998). In addition, endo-
ytosis of some G protein-coupled receptors are regu-
ated by arrestin and Src, whereas others are endocy-
osed in an arrestin- or Src-independent manner (van
oppen, 2001). It will be interesting to identify other tar-
et proteins that are also regulated by endophilin A2
hosphorylation by FAK/Src complex and to determine
he potential differences between proteins regulated by
uch mechanism versus those not affected by it in fu-
ure studies.
In summary, our studies identified endophilin A2 as
n interacting protein with FAK and showed that endo-
hilin A2 association with FAK and its phosphorylation
y the FAK/Src complex could regulate endocytosis and
urface expression of MT1-MMP and consequent cellular
egradation of ECM. They provide new insight into the
echanisms by which FAK promotes cell invasion in




The rabbit polyclonal α-Src, α-HA (Y11), α-FAK (C20), α-pan-
Dynamin, goat polyclonal α-endophilin A2, α-endophilin A1, α-endo-
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195philin A3, and mouse monoclonal α-Myc (9E10) were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA). Streptavidin-conju-
gated agarose, α-HA conjugated agarose, α-Myc conjugated agar-
ose, monoclonal α-Vinculin, FITC conjugating kit, gelatine, and FN
were from Sigma. Rabbit polyclonal α-MT1-MMP was from Re-
search Diagnostics (Flanders, NJ). Monoclonal α-FAK (clone 4.47)
and anti-Phosphotyrosine (4G10) were from Upstate Biotechnology
(Lake Placid, NY). PP2 and PP3 were from Calbiochem (La Jolla,
CA). Texas red-conjugated Phalloidin was from Molecular Probes
(Eugene, OR). NHS-SS-Biotin was from Pierce Biotechnology
(Rockford, IL). Affinity-purified antibody against GST was prepared
from anti-GST serum using GST immobilized on glutathione-Seph-
arose as an affinity matrix. Plasmid DNA construction is described
in the Supplemental Experimental Procedures.
Cell Culture
FAK−/− and FAK+/+ fibroblasts were generous gift of Dr. D. Ilic
(UCSF). They were transformed by stable expression of v-Src,
using plasmids pMV-Src and pPURO to confer puromycin resis-
tance essentially as described (Wu et al., 2004). These and 293T
cells as well as MDA-MB-231 cells were cultured in DMEM plus
10% FBS, and 1.5 g/ml puromycin was also included in media for
the v-Src-transformed cells. NIH3T3 cells were cultured in DMEM
plus 10% CS.
Generation and Infection of Recombinant Adenovirus
The recombinant adenoviruses encoding FAK and its mutants
(Y397F, P878/881A) or endophilin A2 and its mutant (Y315F) were
generated using Adeasy-1 system (Stratagene, CA) according to
manufacturer’s instruction. FAK−/−Src cells were infected at an moi
of 20, whereas FAK+/+Src cells were infected at an moi of 100. No
detectable cell toxicity was observed. Cells were analyzed 48 hr
postinfection.
Immunoprecipitation and Western Blotting
Immunoprecipitation and Western blotting were performed as de-
scribed previously (Wu et al., 2004).
In Vitro Kinase Assay
In vitro kinase assay was performed as described previously (Wu
et al., 2004). HA-tagged FAK or Src were immunoprecipitated from
293T cell lysates transfected with pKH3-FAK or pKH3-Src 527F.
They were used as kinases to phosphorylate GST fusion protein
containing endophilin A2 or its mutants in vitro. In some experi-
ments, purified recombinant Src (a generous gift of Dr. Rick Cerione
of Cornell University) was used.
Preparation of GST Fusion Proteins
and In Vitro Binding Assays
GST fusion proteins were produced, purified, and used in in vitro
binding assays, as described previously (Wu et al., 2004).
Fluorescent Microscopy
Cells were processed for immunofluorescence staining as de-
scribed previously (Wu et al., 2004). The primary antibodies used
were anti-endophilin A2 (1:50), anti-FAK polyclonal antibody C20
(1:50), anti-FAK monoclonal antibody (1:50), and Texas red-conju-
gated phalloidin (1:50). Texas red-conjugated goat-anti-mouse anti-
body (1:200; Jackson ImmunoResearch Laboratory, West Grove,
PA), FITC-conjugated goat-anti-rabbit antibody (1:300; Jackson Im-
munoResearch Laboratory), and FITC-conjugated rabbit-anti-goat
antibody (1:300; Jackson ImmunoResearch Laboratory) were used
as the secondary antibodies.
In-Gel Gelatinase Assay and In Situ Zymography
Gelatin zymography was performed essentially as described
(Hauck et al., 2002). Subconfluent cells were incubated in DMEM
medium without serum at 37°C for 18 hr. The conditioned medium
was collected, clarified by centrifugation, resolved in nonreducing
gels containing 0.05% (w/v) gelatin, and processed for zones of
degradation activity by zymography as described.
For in situ zymography, glass coverslips were prepared essen-
tially as described previously (Berdeaux et al., 2004). In brief, they
were coated with gelatin (0.2 mg/ml in 2% sucrose buffer), cross-linked 15 min in 0.5% glutaraldehyde in PBS, washed with PBS for
30 min, coated with FITC-labeled FN for 60 min at room temper-
ature, rinsed with PBS, fixed with 70% ethanol, and soaked in
DMEM for more than 15 min. Cells were plated on coated cover-
slips in DME containing 10% FBS and incubated at 37°C for 6 hr
before processing for immunostaining. Results were quantified by
counting percentage of cells degrading matrix, as defined by ability
to form at least one degradation patch (50 cells per treatment in at
least three independent experiments).
Cell-Surface Biotinylation and Endocytosis Assay
Cell-surface protein biotinylation and endocytosis assay were per-
formed according to Remacle et al. (2003) with the following modifi-
cations. Subconfluence FAK−/−Src or FAK+/+Src cells in 10 cm
dishes were washed twice with ice-cold PBS and incubated for
a further 15 min in ice-cold PBS. Biotinylation was performed by
incubating cells in PBS containing 0.5 mg/ml of NHS-SS-Biotin for
30 min in 4°C. To determine cell-surface level of MT1-MMP, labeled
cells were lysed, precipitated with streptavidin-conjugated agarose
beads, and subjected to Western blotting with anti-MT1-MMP anti-
body. For endocytosis assay, biotin-labeled cells were washed by
PBS twice, then incubated at 37°C for 15 min to allow endocytosis
before two successive reduction reagent (glutathione) treatment,
which can remove the biotin from cell surface. Cells that were re-
duced by glutathione directly after labeling without incubation in
37°C served as negative control (0 min), while cells that were lysed
directly after labeling without stripping by reduction reagent were
used as positive control. Equal amount of the whole-cell lysate was
precipitated with streptavidin-conjugated agarose beads (with the
exception of positive control, of which only one-fifth was used),
resolved by SDS-PAGE, and blotted by anti-MT1-MMP antibody.
To test the role of Src kinase activity on surface presentation of
MT1-MMP, FAK+/+Src cells were treated with 10 M PP2 for 8 hr
(or 10 M PP3 as a control) before surface biotinylation.
Supplemental Data
Supplemental Data include four figures and Supplemental Experi-
mental Procedures and can be found with this article online at
http://www.developmentalcell.com/cgi/content/full/9/2/185/DC1/.
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